Blood coagulation and fibrinolysis in Ugandan patients with cirrhosis and hepatocellular carcinoma

V. K. Alpidovsky, Charles Vogel, F. Sadikali, A. Primack

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Studies of blood coagulation and fibrinolytic systems were performed in 15 Ugandan Africans with cirrhosis, 29 with hepatocellular carcinoma (14 with and 15 without concomitant cirrhosis) and 20 normal controls. Patients with cirrhosis had decreases in plasma fibrinogen, platelet count and factors of the prothrombin complex and shortening of the euglobulin lysis time. Most patients with hepatocellular carcinoma and no cirrhosis had increased plasma fibrinogen, normal or high platelet counts and normal euglobulin lysis time. In patients with liver cancer and concomitant cirrhosis, mean values for plasma fibrinogen, platelet count and euglobulin lysis time were midway between those of patients with cirrhosis and those with hepatocellular carcinoma. Prolonged thrombin times in several hepatocellular carcinoma patients in the present series, in the absence of fibrinogenopenia, circulating heparin like anticoagulants or increases in fibrinogen degradation products, suggest the possibility that dysfibrinogenaemia may be more common in hepatocellular carcinoma than previously realised.

Original languageEnglish
Pages (from-to)396-408
Number of pages13
JournalEast African Medical Journal
Volume51
Issue number5
StatePublished - Dec 1 1974
Externally publishedYes

Fingerprint

Blood Coagulation
Fibrinolysis
Coagulation
Serum Globulins
Fibrinogen
Hepatocellular Carcinoma
Fibrosis
Blood
Platelets
Fibrin Clot Lysis Time
Platelet Count
Plasmas
Prothrombin
Thrombin
Liver
Anticoagulants
Thrombin Time
Heparin
Liver Neoplasms
Degradation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Blood coagulation and fibrinolysis in Ugandan patients with cirrhosis and hepatocellular carcinoma. / Alpidovsky, V. K.; Vogel, Charles; Sadikali, F.; Primack, A.

In: East African Medical Journal, Vol. 51, No. 5, 01.12.1974, p. 396-408.

Research output: Contribution to journalArticle

@article{23c0c750b0eb49e5a59e2ef3f9df3b45,
title = "Blood coagulation and fibrinolysis in Ugandan patients with cirrhosis and hepatocellular carcinoma",
abstract = "Studies of blood coagulation and fibrinolytic systems were performed in 15 Ugandan Africans with cirrhosis, 29 with hepatocellular carcinoma (14 with and 15 without concomitant cirrhosis) and 20 normal controls. Patients with cirrhosis had decreases in plasma fibrinogen, platelet count and factors of the prothrombin complex and shortening of the euglobulin lysis time. Most patients with hepatocellular carcinoma and no cirrhosis had increased plasma fibrinogen, normal or high platelet counts and normal euglobulin lysis time. In patients with liver cancer and concomitant cirrhosis, mean values for plasma fibrinogen, platelet count and euglobulin lysis time were midway between those of patients with cirrhosis and those with hepatocellular carcinoma. Prolonged thrombin times in several hepatocellular carcinoma patients in the present series, in the absence of fibrinogenopenia, circulating heparin like anticoagulants or increases in fibrinogen degradation products, suggest the possibility that dysfibrinogenaemia may be more common in hepatocellular carcinoma than previously realised.",
author = "Alpidovsky, {V. K.} and Charles Vogel and F. Sadikali and A. Primack",
year = "1974",
month = "12",
day = "1",
language = "English",
volume = "51",
pages = "396--408",
journal = "East African Medical Journal",
issn = "0012-835X",
publisher = "East African Medical Association",
number = "5",

}

TY - JOUR

T1 - Blood coagulation and fibrinolysis in Ugandan patients with cirrhosis and hepatocellular carcinoma

AU - Alpidovsky, V. K.

AU - Vogel, Charles

AU - Sadikali, F.

AU - Primack, A.

PY - 1974/12/1

Y1 - 1974/12/1

N2 - Studies of blood coagulation and fibrinolytic systems were performed in 15 Ugandan Africans with cirrhosis, 29 with hepatocellular carcinoma (14 with and 15 without concomitant cirrhosis) and 20 normal controls. Patients with cirrhosis had decreases in plasma fibrinogen, platelet count and factors of the prothrombin complex and shortening of the euglobulin lysis time. Most patients with hepatocellular carcinoma and no cirrhosis had increased plasma fibrinogen, normal or high platelet counts and normal euglobulin lysis time. In patients with liver cancer and concomitant cirrhosis, mean values for plasma fibrinogen, platelet count and euglobulin lysis time were midway between those of patients with cirrhosis and those with hepatocellular carcinoma. Prolonged thrombin times in several hepatocellular carcinoma patients in the present series, in the absence of fibrinogenopenia, circulating heparin like anticoagulants or increases in fibrinogen degradation products, suggest the possibility that dysfibrinogenaemia may be more common in hepatocellular carcinoma than previously realised.

AB - Studies of blood coagulation and fibrinolytic systems were performed in 15 Ugandan Africans with cirrhosis, 29 with hepatocellular carcinoma (14 with and 15 without concomitant cirrhosis) and 20 normal controls. Patients with cirrhosis had decreases in plasma fibrinogen, platelet count and factors of the prothrombin complex and shortening of the euglobulin lysis time. Most patients with hepatocellular carcinoma and no cirrhosis had increased plasma fibrinogen, normal or high platelet counts and normal euglobulin lysis time. In patients with liver cancer and concomitant cirrhosis, mean values for plasma fibrinogen, platelet count and euglobulin lysis time were midway between those of patients with cirrhosis and those with hepatocellular carcinoma. Prolonged thrombin times in several hepatocellular carcinoma patients in the present series, in the absence of fibrinogenopenia, circulating heparin like anticoagulants or increases in fibrinogen degradation products, suggest the possibility that dysfibrinogenaemia may be more common in hepatocellular carcinoma than previously realised.

UR - http://www.scopus.com/inward/record.url?scp=0016187406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016187406&partnerID=8YFLogxK

M3 - Article

C2 - 4367587

AN - SCOPUS:0016187406

VL - 51

SP - 396

EP - 408

JO - East African Medical Journal

JF - East African Medical Journal

SN - 0012-835X

IS - 5

ER -